Kumamoto Rosai Hospital
Kumamoto Yatsushiro, Japan
Hospital in Yatsushiro
1670 Takeharamachi, Yatsushiro, Kumamoto 866-0826
About Kumamoto Rosai Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Clinical Trials at Kumamoto Rosai Hospital
During the past decade, Kumamoto Rosai Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kumamoto Rosai Hospital"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Kumamoto Rosai Hospital
According to Clinical.Site data, the most researched conditions in "Kumamoto Rosai Hospital" are
"Heart Failure" (2 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Kumamoto Rosai Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kumamoto Rosai Hospital
Most popular intervention types in "Kumamoto Rosai Hospital" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "glimepiride" (1 trials), "glimepiride placebo" (1 trials) and "linagliptin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kumamoto Rosai Hospital
The vast majority of trials in "Kumamoto Rosai Hospital" are
3 trials for "All" genders.
Clinical Trials Status at Kumamoto Rosai Hospital
Currently, there are NaN active trials in "Kumamoto Rosai Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Kumamoto Rosai Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kumamoto Rosai Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".